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A B S T R A C T
It is presented a case of a 32-year-old male with the three primary tumors diagnosed within a time period of 3 years;
retroperitoneal nonseminoma in 2002, retroperitoneal mature teratoma in 2004, and metachronous testicular seminoma
in 2005. We discuss the unusual presentation of these three rare events occurring in the same patient without known risk
factors.
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Introduction
In a last few decades it was achieved a great success in
GCT (germ cell tumors) treatment with more than 90%
of patients are being cured, but unfortunately this was
not paralleled with better understanding of disease etiol-
ogy. The incidence of testicular cancer has almost dou-
bled in most Western countries over the last 25 years.
Temporal and geographic variation in incidences stron-
gly suggests environmental etiologic factors. The in-
creasing incidence has paralleled decline in semen quality
over the last several decades. It has been hypothesized
that both testicular cancer and male subfertility may be
caused by intrauterine exposure of the developing male
embryo to factors that alter the hormonal balance. There
is also evidence of genetic component to the development
of testis cancer.
Case Report
A 32-year-old man was admitted to our hospital in
year 2002 to evaluate an asymptomatic, palpable abdom-
inal mass, approximately 7 cm in diameter, located on the
right side of umbilicus. Computed tomography (CT) sho-
wed an aorto-caval retroperitoneal tumor which spread
out into the iliac blood vessels on the right side. There
was no evidence of tumor in the testes by testicular pal-
pation or echography.
Surgical extirpation of tumor was performed in Au-
gust 2002. The diagnosis was retroperitoneal extrago-
nadal nonseminoma with predominantly yolk-sac tumor
with elements of embrional carcinoma (Figure 1). Al-
pha-fetoprotein (AFP) was highly positive in pathological
specimen. Postoperative AFP in serum was 2,892 kIU/L;
lactate dehydrogenase (LDH) was within normal limits,
as well as human chorionic gonadotropin (HCG). Postope-
rative CT revealed enlarged retroperitoneal lymph nodes.
The patient was advised for sperm banking. Sperm
analysis confirmed normozoospermia. Patient has nega-
tive family history in relation to germ cell tumors, and he
denies cryptorhidism in childhood; patient was not te-
sted for chromosomal abnormality. He became a father of
one child before onset of the disease.
Four courses of adjuvant chemotherapy BEP (bleo-
mycin, etoposide and cisplatin) were performed. Com-
plete remission was achieved.
After three months, retroperitoneal MRI still showed
enlarged retroperitoneal lymph nodes; AFP and HCG
were within normal limits. Retroperitoneal lymphadene-
937
Received for publication December 28, 2010
ctomy was performed in February 2004. Histopathology
diagnosis was mature teratoma.
In September 2005, he noticed a lump in his right tes-
ticle. Radical right inguinal orchiectomy was performed.
Pathological tests showed pure seminoma limited to the
testis with the elements of intratubular germ-cell neo-
plasia (Figure 2), stage IA, pT1N0M0. LDH, HCG and
AFP levels were not elevated. To reduce risk of relapse,
we administered two cycles of VIP (cisplatin, etoposide,
ifosfamide) chemotherapy and he was followed up (radio-
therapy was avoided due to potential adverse effects-pre-
vious retroperitoneal operations).
After 2 years CT showed a new retroperitoneal tumor
mass (Figure 3). FDG-PET demonstrated a significant
radiotracer uptake in this tumor. US of the remaining
left testis was normal. Tumor markers AFP, HCG and
LDH were also normal. In year 2007, for the third time,
retroperitoneal surgery was performed (second retro-
peritoneal tumor extirpation). Metastatic seminoma was
diagnosed, and the patient received four cycles of VIP
chemotherapy.
Six months later, PET showed a small focus of ra-
diotracer uptake retroperitoneally and in left testis. It
was decided to proceed with surgical exploration of soli-
tary left testis, and intra-operative biopsy did not con-
firm malignant tumor (July 2008).
We decided to follow-up the patient. Up to now all lab-
oratory findings and tumor markers have been normal,
CT scans and PET/CT done in February 2010 were with-
out signs of disease.
He has an excellent performance status without any
major health problems eight years from the beginning of
the treatment (Figure 4). Since surgery in 2004 he did
not have ejaculation, but in last six months he has ejacu-
lation again; however, the ejaculatory volume was de-
creased.
Patient has negative family history in relation to
germ cell tumors, he denies cryptorhidism in childhood
and was not tested for chromosomal abnormality, for ex-
ample Klinefelter’s syndrome, that has been associated
with extragonadal GCT with highest frequency1. Our pa-
tient became a father of one child before onset of the dis-
ease.
Discussion
Although germ cell tumors (GCT) are relatively un-
common tumors comprising only 2% of all human malig-
nancies, they constitute the most common solid tumor in
men between ages of 15 and 34 years. Germ cell tumors
arise 95% in testes and remaining 5% are of extragonadal
origin.
Primordial germ cells migrate by the fifth week of
gestation through the mesentery to the gonadal ridge.
Extragonadal tumors are presumed to arise from germ
cells that have migrated aberrantly. Another hypothesis
is that these tumors arise from totipotent embryonal
cells that have escaped the influence of embryonic orga-
nizers controlling normal differentiation.
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Fig. 1. Glandular-alveolar pattern of Yolk-sac tumour (irregular
alveolar and gland-like spaces lined by flattened to cuboid cells).
H&E x 40.
Fig. 2. Histopathological examination: seminoma, H&E x 40.
Fig. 3. Abdominal MSCT with metastatic lymph node disease
(year 2007).
It is a known fact that patients with testis germ cell
tumor (TGCT) have increased risk for developing con-
tralateral testis tumor as well. Most bilateral TGCT de-
velop metachronously and are seminomas. Both synchro-
nous and metachronous bilateral TGCT have similar,
excellent prognosis. Patients with unilateral TGCT re-
quire careful long-term monitoring of the remaining tes-
ticle due to a 26-fold increased risk for contra-lateral dis-
ease and a potentially long risk interval of up to 25
years2. The most reported incidence of metachronous bi-
lateral testes tumors is between 2–4%2–4.
Even rarer is incidence for metachronous testicular
germ cell tumor with primary extragonadal germ cell tu-
mors (EGCT). Patients with EGCTs, particularly those
with retroperitoneal or nonseminomatous tumors, are at
an increased risk for metachronous testicular cancer. In
Hartmann’s retrospective study, 4.1% of patients devel-
oped metachronous testicular tumor5.
Various studies have suggested the presence of an in-
herited predisposition for the development of these tu-
mors. Completion of the human gene map and advances
in genetic research will facilitate further investigation of
genetic predisposition to GCT. Insight of GCT inheri-
tance might lead to the identification of individuals at in-
creased risk for developing the disorder, increase our un-
derstanding of the mutation pathways that lead to spora-
dic cases, and contribute to improvement in diagnosis
and treatment. Clinicians should record the family his-
tory of cancer and urogenital differentiation defects in
patients with GCT6.
In case of our patient, his first diagnosis was an
extragonadal germ cell tumor. Pretreatment testicular
biopsy was not performed because it is still a controver-
sial issue. After surgical treatment and adjuvant cispla-
tin based chemotherapy, normalization of tumor marker
and complete radiological response was achieved, but
very shortly it became evident that retroperitoneal mass
actually increased in size. Due to patohistological diagno-
sis of mature teratoma that appeared after successful
treatment of nonseminoma, we concluded that this con-
dition represented growing teratoma syndrome (GTS).
Growing teratoma syndrome was first described by
Logothesis et al. in 1982 and was characterized by en-
larging metastases of nonseminoma germ cell tumors de-
spite appropriate chemotherapy and normalized serum
markers. The prevalence was only 1.9–7.6%7. Despite the
fact that most authors describe GTS in metastatic le-
sions of nonseminoma germ cell tumors, it also has been
observed in primary tumors8,9. Since GTS is a rare event
it should be kept in mind treating nonseminoma pa-
tients.
According to analysis of Hashimoto and colleagues,
HCG was a significant marker in all five reported cases,
that led to detection of MTGCT10, but in our case HCG
was normal during the whole course of disease, even in
the retroperitoneal seminoma metastases.
We have a patient with three very rare events: extra-
gonadal nonseminoma, metachronous gonadal semino-
ma and teratoma growing syndrome. Eight years from
the beginning of disease he has no signs of disease or ma-
jor health problems. His quality of life is excellent.
Patients with this kind of medical history require
long-term close monitoring due to increased risk for
contralateral testis tumors, other possible germ cell tu-
mors or secondary tumors induced by chemotherapeutic
drugs. There is also a great importance of patient’s edu-
cation and self-examination of testis. According to litera-
ture review, this is the 25th case of metachronous te-
sticular tumor developing after retroperitoneal EGCT,
but to our knowledge this may be the first case report
published, in which two germ cell tumors with different
histology occurred metachronously together with tera-
toma growing syndrome.
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Fig. 4. Timeline with course of disease; 1Histopathological exami-
nation.
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RETROPERITONEALNI I METAKRONI GERMINATIVNI TUMORI TESTISA RAZLI^ITE
HISTOLOGIJE I SINDROM RASTU]EG TERATOMA – PRIKAZ SLU^AJA
S A @ E T A K
Prikazujemo slu~aj 32-godi{njeg bolesnika kod kojeg je unutar tri godine postavljena dijagnoza tri primarna tumora
razli~ite histologije: retroperitonealni neseminoma 2002. godine, retroperitonealni zreli teratom 2004. godine i me-
takroni seminom testisa 2005. godine. Ovdje raspravljamo o neobi~noj pojavi tri rijetka doga|aja u istog bolesnika bez
poznatih rizi~nih ~imbenika.
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